Friday, February 22, 2019

Dr. Nathan Treff (Genomic Prediction) at COGEN 2019 (Paris)

Chief Science Officer of Genomic Prediction, Dr. Nathan Treff, presents to a packed audience at COGEN 2019 (Paris) on Expanded Preimplantation Genetic Testing (ePGT), describing Genomic Prediction's initial validation study, and the first PGT-P application to human biopsy samples.
COGEN focuses on Innovation in Preconception, Preimplantation and Prenatal Genetic Diagnosis, including:

Pre-Congress Courses on Basic Genetic Principles for the Non-Geneticists

Basic research on oocyte aging and the origin of aneuploidy

The use of Next Generation Sequencing for expanded preconception carrier screening

Novel strategies for Non-Invasive Prenatal Testing (NIPT) and Non-invasive Prenatal Diagnosis (NIPD)

The use of Whole Exome/Genome Sequencing (WES/WGS) in the evaluation of the malformed fetus

Preimplantation Genetic Testing for Aneuploidy (PGT-A) for detection of chromosome copy number abnormalities in human embryos and oocytes

Preimplantation Genetic Testing for monogenic disorders (PGT-M) and structural rearrangements (PGT-SR)

Genetic factors in implantation

The Faculty: World-renowned scientists and physicians in the field.

The COGEN Congress is a unique educational opportunity for practitioners in the field of human procreation to conduct discussions and network with leading experts. ...


Simon Fishel, Yuval Yaron & Alexandra Benachi

No comments:

Blog Archive